Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,522,554
-
Share change
-
+447,760
-
Total reported value
-
$12,390,775
-
Price per share
-
$8.16
-
Number of holders
-
16
-
Value change
-
+$3,680,477
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q2 2023
As of 30 Jun 2023,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,522,554 shares.
The largest 10 holders included
Roumell Asset Management, LLC, PINNACLE ASSOCIATES LTD, VILLERE ST DENIS J & CO LLC, BROWN ADVISORY INC, BENJAMIN F. EDWARDS & COMPANY, INC., Zurcher Kantonalbank (Zurich Cantonalbank), BANK OF AMERICA CORP /DE/, UBS Group AG, PNC Financial Services Group, Inc., and FNY Investment Advisers, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.